OBJECTIVE: To examine the effectiveness of the health system response to the challenge of diabetes across different settings and explore the inequalities in diabetes care that are attributable to socioeconomic factors. METHODS: We used nationally representative health examination surveys from Colombia, England, the Islamic Republic of Iran, Mexico, Scotland, Thailand and the United States of America to obtain data on diagnosis, treatment and control of hyperglycaemia, arterial hypertension and hypercholesterolaemia among individuals with diabetes. Using logistic regression, we explored the socioeconomic determinants of diagnosis and effective case management. FINDINGS: A substantial proportion of individuals with diabetes remain undiagnosed and untreated, both in developed and developing countries. The figures range from 24% of the women in Scotland and the USA to 62% of the men in Thailand. The proportion of individuals with diabetes reaching treatment targets for blood glucose, arterial blood pressure and serum cholesterol was very low, ranging from 1% of male patients in Mexico to about 12% in the United States. Income and education were not found to be significantly related to the rates of diagnosis and treatment anywhere except in Thailand, but in the three countries with available data insurance status was a strong predictor of diagnosis and effective management, especially in the United States. CONCLUSION: There are many missed opportunities to reduce the burden of diabetes through improved control of blood glucose levels and improved diagnosis and treatment of arterial hypertension and hypercholesterolaemia. While no large socioeconomic inequalities were noted in the management of individuals with diabetes, financial access to care was a strong predictor of diagnosis and management.
OBJECTIVE: To examine the effectiveness of the health system response to the challenge of diabetes across different settings and explore the inequalities in diabetes care that are attributable to socioeconomic factors. METHODS: We used nationally representative health examination surveys from Colombia, England, the Islamic Republic of Iran, Mexico, Scotland, Thailand and the United States of America to obtain data on diagnosis, treatment and control of hyperglycaemia, arterial hypertension and hypercholesterolaemia among individuals with diabetes. Using logistic regression, we explored the socioeconomic determinants of diagnosis and effective case management. FINDINGS: A substantial proportion of individuals with diabetes remain undiagnosed and untreated, both in developed and developing countries. The figures range from 24% of the women in Scotland and the USA to 62% of the men in Thailand. The proportion of individuals with diabetes reaching treatment targets for blood glucose, arterial blood pressure and serum cholesterol was very low, ranging from 1% of male patients in Mexico to about 12% in the United States. Income and education were not found to be significantly related to the rates of diagnosis and treatment anywhere except in Thailand, but in the three countries with available data insurance status was a strong predictor of diagnosis and effective management, especially in the United States. CONCLUSION: There are many missed opportunities to reduce the burden of diabetes through improved control of blood glucose levels and improved diagnosis and treatment of arterial hypertension and hypercholesterolaemia. While no large socioeconomic inequalities were noted in the management of individuals with diabetes, financial access to care was a strong predictor of diagnosis and management.
Authors: Panrasri Khonputsa; J Lennert Veerman; Theo Vos; Wichai Aekplakorn; Melanie Bertram; Jesse Abbott-Klafter; Margaret C Hogan; Stephen S Lim Journal: Asia Pac J Public Health Date: 2010-08-03 Impact factor: 1.399
Authors: Juan A Rull; Carlos A Aguilar-Salinas; Rosalba Rojas; Juan Manuel Rios-Torres; Francisco J Gómez-Pérez; Gustavo Olaiz Journal: Arch Med Res Date: 2005 May-Jun Impact factor: 2.235
Authors: Salvador Villalpando; Vanessa de la Cruz; Rosalba Rojas; Teresa Shamah-Levy; Marco Antonio Avila; Berenice Gaona; Rosario Rebollar; Lucia Hernández Journal: Salud Publica Mex Date: 2010
Authors: Kristian B Filion; Lawrence Joseph; Jean-François Boivin; Samy Suissa; James M Brophy Journal: Pharmacoepidemiol Drug Saf Date: 2009-10 Impact factor: 2.890
Authors: Nayu Ikeda; David Sapienza; Ramiro Guerrero; Wichai Aekplakorn; Mohsen Naghavi; Ali H Mokdad; Rafael Lozano; Christopher J L Murray; Stephen S Lim Journal: Bull World Health Organ Date: 2013-09-30 Impact factor: 9.408
Authors: Julia A Critchley; Blanca I Restrepo; Katharina Ronacher; Anil Kapur; Andrew A Bremer; Larry S Schlesinger; Randall Basaraba; Hardy Kornfeld; Reinout van Crevel Journal: Chest Date: 2017-04-20 Impact factor: 9.410
Authors: Perianayagam Arokiasamy; Paul Kowal; Benjamin D Capistrant; Theresa E Gildner; Elizabeth Thiele; Richard B Biritwum; Alfred E Yawson; George Mensah; Tamara Maximova; Fan Wu; Yanfei Guo; Yang Zheng; Sebastiana Zimba Kalula; Aarón Salinas Rodríguez; Betty Manrique Espinoza; Melissa A Liebert; Geeta Eick; Kirstin N Sterner; Tyler M Barrett; Kwabena Duedu; Ernest Gonzales; Nawi Ng; Joel Negin; Yong Jiang; Julie Byles; Savathree Lorna Madurai; Nadia Minicuci; J Josh Snodgrass; Nirmala Naidoo; Somnath Chatterji Journal: Am J Epidemiol Date: 2017-03-15 Impact factor: 4.897
Authors: Anita V Neutzsky-Wulff; Kim V Andreassen; Sara T Hjuler; Michael Feigh; Anne-Christine Bay-Jensen; Qinlong Zheng; Kim Henriksen; Morten A Karsdal Journal: J Transl Med Date: 2012-10-30 Impact factor: 5.531